PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 83 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,346 | -25.5% | 2,793 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $9,859 | +14.2% | 2,793 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $8,630 | -27.0% | 2,793 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $11,814 | +68.8% | 2,793 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $7,000 | -12.5% | 2,793 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $8,000 | 0.0% | 2,793 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $8,000 | 0.0% | 2,793 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $8,000 | -60.0% | 2,793 | 0.0% | 0.00% | -80.0% |
| Q3 2021 | $20,000 | -23.1% | 2,793 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $26,000 | -3.7% | 2,793 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $27,000 | -6.9% | 2,793 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $29,000 | +3.6% | 2,793 | 0.0% | 0.01% | -12.5% |
| Q3 2020 | $28,000 | -3.4% | 2,793 | 0.0% | 0.01% | -11.1% |
| Q2 2020 | $29,000 | +20.8% | 2,793 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $24,000 | 0.0% | 2,793 | 0.0% | 0.01% | +12.5% |
| Q4 2019 | $24,000 | – | 2,793 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |